Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-01-01 @ 8:37 AM
Study NCT ID:
NCT00780169
Status:
COMPLETED
Last Update Posted:
2013-05-13
First Post:
2008-10-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer
Sponsor:
Ottawa Hospital Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
OTT 06-08
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |